Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Breast Neoplasms 15Neoplasms 12Carcinoma, Hepatocellular 12Uterine Cervical Neoplasms 10Esophageal Neoplasms 10Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 8Ovarian Neoplasms 6Carcinoma, Ovarian Epithelial 6Melanoma 5Lung Neoplasms 5Colorectal Neoplasms 5Thyroid Cancer, Papillary 4Stomach Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Motor Activity 4Hematologic Neoplasms 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Colonic Neoplasms 4Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Pain 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Esophageal Squamous Cell Carcinoma 3Uveal Melanoma 2Thyroid Neoplasms 2Skin Neoplasms 2

Interventions

Lisaftoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER_GOV × Leukemia, Promyelocytic, Acute × Clear all
NCT07597941 2026-06-04

Lisaftoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia Patients

The Affiliated People's Hospital of Ningbo University

Phase 2/3 Not yet recruiting
60 enrolled
Other hematologic neoplasm

Leukemia, Promyelocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡